Meeting
2018 ASCO Annual Meeting
Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?
Authors
Andrea Phillips Sitlinger
Duke University Medical Center, Durham, NC
Andrea Phillips Sitlinger , Rishi Sachdev , Peter A. Ubel , Charlene Wong , Thomas William LeBlanc , Tian Zhang , David Anderson , Yousuf Zafar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6620)
DOI
10.1200/JCO.2018.36.15_suppl.6620
Abstract #
6620
Poster Bd #
445
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Quality Care Symposium
Can oral chemotherapy parity laws reduce patients’ out-of-pocket (OOP) costs?
First Author: Andrea Phillips Sitlinger
Poster
2024 ASCO Genitourinary Cancers Symposium
Real-world treatment (Tx) sequences and time to discontinuation (rwTTD) in the first-line (1L) metastatic castration-resistant prostate cancer (mCRPC) setting.
First Author: Emily Nash Smyth
Poster
2022 ASCO Annual Meeting
A phase 2 randomized study of oral docetaxel plus ritonavir (ModraDoc006/r) in patients with metastatic castration-resistant prostate cancer (mCRPC).
First Author: Ulka N. Vaishampayan
Poster
2022 ASCO Genitourinary Cancers Symposium
Practice patterns in the management of metastatic castration-sensitive prostate cancer: A single-center survey-based study.
First Author: Eric Lu